NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11.6 mln
Float17.86 mln
Earnings Date05/14/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
-0.20
Negative equity
ROE
-512
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Lunai Bioworks Inc. is a Los Angeles-based biotechnology company operating in the United States and the Netherlands, focused on developing treatments and diagnostic tools for cancer. The company is working on genetically engineered cell-based vaccines designed to target solid tumors, including pancreatic and breast cancers, alongside an artificial intelligence platform that can detect cancer and its return at an early stage, even before symptoms appear. Formerly known as Renovaro Inc., the company also has a presence in biodefense.
